A signifiant milestone for our publication on Nutrients journal
We wanted to highlight on our recent article on our psychopharmacology research "The Anxiolytic-like Properties of a Tryptic Hydrolysate of Bovine αs1 Casein Containing α-Casozepine Rely on GABAA Receptor Benzodiazepine Binding Sites but Not the Vagus Nerve" that has reached over 3000 views in MDPI Nutrients journal! The published data on the anxiolytic-like properties of bovine αs1-casein (CH) support that: α-casozepine is responsive for the anxiolytic-like effects of the alpha-s1-casein tryptic hydrolysate (CH). CH anxiolytic-like effects are not mediated by the
POSTER: “Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations”
Dr Annelise LETOURNEUR, Director of Operations at STROK@LLIANCE and Neuroscience Study Director, presented the team's research* during the American Heart Association’s annual International Stroke Conference 2025, in Los Angeles, in her poster "Translational Relevance and Versatility of the Thromboembolic Stroke Model in Mice: Implications for Pharmacological and Safety Evaluations". Learn more about our original preclinical results for in vivo trials on stroke disease, see the poster! Until the poster is available here, don't wait any longer and ask for the poster in
Health Investigation on French TV: “Our Lives with Parkinson’s”
🎥 Today we're sharing a documentary about Parkinson's on the famous French program "Health Investigation: Our Lives with Parkinson's" Parkinson's disease is the second leading cause of motor disability in adults after strokes, with 25,000 new cases each year in France. To date, there is no cure for this complex disorder, so research continues ! 🧠 In this documentary, journalist and producer Joseph Coriat, diagnosed at 38, shares his experience and meets with 6 persons to talk about daily life with